Ifitm3 Limits the Severity of Acute Influenza in Mice

English version České info

Interferon-induced transmembrane (IFITM) proteins are a family of viral restriction factors that inhibit the entry processes of several pathogenic viruses, including influenza A virus (IAV), in vitro. Here we report that IAV-infected knockout mice lacking the Ifitm locus on chromosome 7 exhibited accelerated disease progression, greater mortality, and higher pulmonary and systemic viral burdens as compared to wild type controls. We further observed that the phenotype of Ifitm3-specific knockout mice was indistinguishable from that of mice lacking the entire Ifitm locus. Ifitm3 was expressed by IAV target cells including alveolar type II pneumocytes and tracheal/bronchial respiratory epithelial cells. Robust Ifitm3 expression was also observed in several tissues in the absence of infection. Among murine Ifitm promoters, only that of Ifitm3 could be induced by type I and II interferons. Ifitm3 could also be upregulated by the gp130 cytokines IL-6 and oncostatin M on cells expressing appropriate receptors, suggesting that multiple cytokine signals could contribute to Ifitm3 expression in a cell or tissue-specific manner. Collectively, these findings establish a central role for Ifitm3 in limiting acute influenza in vivo, and provide further insight into Ifitm3 expression and regulation.

Vyšlo v časopise: Ifitm3 Limits the Severity of Acute Influenza in Mice. PLoS Pathog 8(9): e32767. doi:10.1371/journal.ppat.1002909
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002909

Souhrn

Zdroje

1. SchogginsJW, WilsonSJ, PanisM, MurphyMY, JonesCT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481–485.

2. BrassAL, HuangIC, BenitaY, JohnSP, KrishnanMN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243–1254.

3. ShapiraSD, Gat-ViksI, ShumBOV, DricotA, de GraceMM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255–1267.

4. HuangIC, BaileyCC, WeyerJL, RadoshitzkySR, BeckerMM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7: e1001258–e1001258.

5. JiangD, WeidnerJM, QingM, PanXB, GuoH, et al. (2010) Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84: 8332–8341.

6. WeidnerJM, JiangD, PanX-B, ChangJ, BlockTM, et al. (2010) Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84: 12646–12657.

7. AlberD, StaeheliP (1996) Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9–27 protein. J Interferon Cytokine Res 16: 375–380.

8. LuJ, PanQ, RongL, HeW, LiuS-L, et al. (2011) The IFITM proteins inhibit HIV-1 infection. J Virol 85: 2126–2137.

9. FeeleyEM, SimsJS, JohnSP, ChinCR, PertelT, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7: e1002337.

10. WeeYS, RoundyKM, WeisJJ, WeisJH (2012) Interferon-inducible transmembrane proteins of the innate immune response act as membrane organizers by influencing clathrin and v-ATPase localization and function. Innate Immun E-pub ahead of print.

11. HuangIC, BoschBJ, LiF, LiW, LeeKH, et al. (2006) SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem 281: 3198–3203.

12. HickfordDE, FrankenbergSR, ShawG, RenfreeMB (2012) Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics 13: 155.

13. LangeUC, AdamsDJ, LeeC, BartonS, SchneiderR, et al. (2008) Normal Germ Line Establishment in Mice Carrying a Deletion of the Ifitm/Fragilis Gene Family Cluster. Mol Cell Biol 28: 4688–4696.

14. MoffattP, GaumondM-H, SaloisP, SellinK, BessetteM-C, et al. (2008) Bril: A Novel Bone-Specific Modulator of Mineralization. J Bone Miner Res 23: 1497–1508.

15. HanagataN, LiX, MoritaH, TakemuraT, LiJ, et al. (2011) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29: 279–290.

16. PriceGE, Gaszewska-MastarlarzA, MoskophidisD (2000) The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J Virol 74: 3996–4003.

17. KlenkHD, GartenW (1994) Host cell proteases controlling virus pathogenicity. Trends Microbiol 2: 39–43.

18. García-SastreA, DurbinRK, ZhengH, PaleseP, GertnerR, et al. (1998) The role of interferon in influenza virus tissue tropism. J Virol 72: 8550–8558.

19. SunX, TseLV, FergusonAD, WhittakerGR (2010) Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus. J Virol 84: 8683–8690.

20. BottcherE, MatrosovichT, BeyerleM, KlenkHD, GartenW, et al. (2006) Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol 80: 9896–9898.

21. LarreaE, AldabeR, GonzalezI, SeguraV, SarobeP, et al. (2009) Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells. J Virol 83: 3298–3311.

22. SilverJS, HunterCA (2010) gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol 88: 1145–1156.

23. FriedmanRL, ManlySP, McMahonM, KerrIM, StarkGR (1984) Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38: 745–755.

24. IbricevicA, PekoszA, WalterMJ, NewbyC, BattaileJT, et al. (2006) Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 80: 7469–7480.

25. SalaunB, de Saint-VisB, PachecoN, PachecoY, RieslerA, et al. (2004) CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes. Am J Pathol 164: 861–871.

26. EverittAR, ClareS, PertelT, JohnSP, WashRS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519–523.

27. World Health Organization (2009) CDC protocol of realtime RTPCR for influenza A (H1N1). Geneva: World Health Organization. Available: http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/index.html.

28. HuangIC, LiW, SuiJ, MarascoW, ChoeH, et al. (2008) Influenza A virus neuraminidase limits viral superinfection. J Virol 82: 4834–4843.